113 related articles for article (PubMed ID: 15225142)
1. Increased expression of G-protein-coupled receptor kinases 3 and 4 in hyperfunctioning thyroid nodules.
Voigt C; Holzapfel HP; Meyer S; Paschke R
J Endocrinol; 2004 Jul; 182(1):173-82. PubMed ID: 15225142
[TBL] [Abstract][Full Text] [Related]
2. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
Holzapfel HP; Bergner B; Wonerow P; Paschke R
Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of G-protein coupled receptor kinase 2 in cold thyroid nodules.
Voigt C; Holzapfel HP; Paschke R
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):102-6. PubMed ID: 15772902
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of G protein-coupled receptor kinase 5 and beta-arrestin-1 in rat thyroid FRTL5 cells.
Nagayama Y; Tanaka K; Namba H; Yamashita S; Niwa M
Thyroid; 1996 Dec; 6(6):627-31. PubMed ID: 9001199
[TBL] [Abstract][Full Text] [Related]
5. Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules.
Stephenson A; Eszlinger M; Stewardson P; McIntyre JB; Boesenberg E; Bircan R; Sancak S; Gozu HI; Ghaznavi S; Krohn K; Paschke R
Thyroid; 2020 Oct; 30(10):1482-1489. PubMed ID: 32284013
[No Abstract] [Full Text] [Related]
6. Expression of beta-arrestins in toxic and cold thyroid nodules.
Voigt C; Holzapfel H; Paschke R
FEBS Lett; 2000 Dec; 486(3):208-12. PubMed ID: 11119705
[TBL] [Abstract][Full Text] [Related]
7. Growth factor expression in cold and hot thyroid nodules.
Eszlinger M; Krohn K; Kratzsch J; Voigt C; Paschke R
Thyroid; 2001 Feb; 11(2):125-35. PubMed ID: 11288981
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of g protein-coupled receptor kinases in differentiated thyroid carcinoma.
Métayé T; Menet E; Guilhot J; Kraimps JL
J Clin Endocrinol Metab; 2002 Jul; 87(7):3279-86. PubMed ID: 12107237
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan.
Nishihara E; Amino N; Maekawa K; Yoshida H; Ito M; Kubota S; Fukata S; Miyauchi A
Endocr J; 2009; 56(6):791-8. PubMed ID: 19550078
[TBL] [Abstract][Full Text] [Related]
10. Involvement of G protein-coupled receptor kinase 5 in homologous desensitization of the thyrotropin receptor.
Nagayama Y; Tanaka K; Hara T; Namba H; Yamashita S; Taniyama K; Niwa M
J Biol Chem; 1996 Apr; 271(17):10143-8. PubMed ID: 8626574
[TBL] [Abstract][Full Text] [Related]
11. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
[TBL] [Abstract][Full Text] [Related]
12. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan.
Takeshita A; Nagayama Y; Yokoyama N; Ishikawa N; Ito K; Yamashita T; Obara T; Murakami Y; Kuma K; Takamatsu J
J Clin Endocrinol Metab; 1995 Sep; 80(9):2607-11. PubMed ID: 7673402
[TBL] [Abstract][Full Text] [Related]
13. Expression of G-protein-coupled receptor kinases in pregnant term and non-pregnant human myometrium.
Brenninkmeijer CB; Price SA; López Bernal A; Phaneuf S
J Endocrinol; 1999 Sep; 162(3):401-8. PubMed ID: 10467231
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4.
Watanabe H; Xu J; Bengra C; Jose PA; Felder RA
Kidney Int; 2002 Sep; 62(3):790-8. PubMed ID: 12164861
[TBL] [Abstract][Full Text] [Related]
15. G protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs.
Kageyama K; Hanada K; Moriyama T; Nigawara T; Sakihara S; Suda T
Endocrinology; 2006 Jan; 147(1):441-50. PubMed ID: 16195412
[TBL] [Abstract][Full Text] [Related]
16. Identification by polymerase chain reaction of the G protein-coupled receptor kinases expressed in the mouse gonadotropic alpha T3-1 cell line.
Neill JD; Musgrove LC; Sellers JC; Duck LW
Endocrinology; 1996 Sep; 137(9):3942-7. PubMed ID: 8756570
[TBL] [Abstract][Full Text] [Related]
17. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
18. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S
Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of G protein-linked receptor kinases with advancing age in rat aorta.
Schutzer WE; Reed JF; Bliziotes M; Mader SL
Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R897-903. PubMed ID: 11171671
[TBL] [Abstract][Full Text] [Related]
20. Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation.
Nishihara E; Chen CR; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
J Endocrinol Invest; 2012 Jan; 35(1):49-53. PubMed ID: 21597314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
